Alimera Sciences, Inc.
The momentum for this stock is not very good. Alimera Sciences, Inc. is not very popular among insiders. Alimera Sciences, Inc. is a mediocre stock to choose.
Log in to see more information.
Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It ope...
News
Alimera Sciences: Deal Closing After All, CVR Still Attractive
SeekingAlpha Alimera Sciences: Deal Closing After All, CVR Still Attractive...\n more…
ANI Pharmaceuticals, Alimera Sciences deal set to close Monday
Seeking Alpha - Healthcare ANI Pharmaceuticals, Alimera Sciences deal set to close Monday...\n more…
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
Globe Newswire ANI and Alimera Scheduled the Closing for September 16, 2024PRINCETON, N.J. and ATLANTA, Sept. 11, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) ( ANI ) and Alimera Sciences...\n more…
Alimera Sciences falls after it sues ANI Pharmaceuticals to close deal (update)
SeekingAlpha.com: All News Alimera Sciences files lawsuit against ANI Pharmaceuticals over failed merger, causing stock to plummet 25% in premarket trading.\n more…